Short‐ and long‐term therapy for reflux oesophagitis in the elderly: a multi‐centre, placebo‐controlled study with pantoprazole
暂无分享,去创建一个
[1] D. Metz,et al. Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis , 2003, Alimentary pharmacology & therapeutics.
[2] A. Pilotto,et al. Long-Term Clinical Outcome of Elderly Patients With Reflux Esophagitis: A Six-Month to Three-Year Follow-up Study , 2002, American journal of therapeutics.
[3] A. Pilotto,et al. Influence of Helicobacter pylori infection on severity of oesophagitis and response to therapy in the elderly. , 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[4] A. Ferrari,et al. Efficacy and tolerability of pantoprazole versus ranitidine in the treatment of reflux esophagitis and the influence of Helicobacter pylori infection on healing rate. , 2002, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.
[5] J. Polak,et al. Pantoprazole therapy in the long-term management of severe acid peptic disease Clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies , 2001, American Journal of Gastroenterology.
[6] J. Polak,et al. Pantoprazole therapy in the long-term management of severe acid peptic disease , 2001 .
[7] G. I. Leontiadis,et al. Meta‐analysis of randomized controlled trials comparing standard clinical doses of omeprazole and lansoprazole in erosive oesophagitis , 2001, Alimentary pharmacology & therapeutics.
[8] U. Klotz. Pharmacokinetic Considerations in the Eradication of Helicobacter Pylori , 2000, Clinical pharmacokinetics.
[9] J. Richter,et al. Gastroesophageal reflux disease in the older patient: presentation, treatment, and complications. , 2000, The American journal of gastroenterology.
[10] J. Richter. GI Problems in Geriatric Patients , 2000, American Journal of Gastroenterology.
[11] J. Escourrou,et al. Maintenance therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitis , 1999, Alimentary pharmacology & therapeutics.
[12] Honiball,et al. Safety and efficacy of pantoprazole 40 mg daily as relapse prophylaxis in patients with healed reflux oesophagitis—a 2‐year follow‐up , 1999, Alimentary pharmacology & therapeutics.
[13] P. Malfertheiner,et al. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole. , 1999, Gastroenterology.
[14] Y. Kinoshita,et al. Relationship between severity and symptoms of reflux oesophagitis in elderly patients in Japan , 1998, Journal of gastroenterology and hepatology.
[15] C. Maier,et al. One‐year prophylactic efficacy and safety of pantoprazole in controlling gastro‐oesophageal reflux symptoms in patients with healed reflux oesophagitis , 1997, Alimentary pharmacology & therapeutics.
[16] A. Berstad,et al. Prognostic factors for relapse of reflux oesophagitis and symptoms during 12 months of therapy with lansoprazole , 1997, Alimentary pharmacology & therapeutics.
[17] R. Hunt,et al. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. , 1997, Gastroenterology.
[18] A. Pilotto,et al. A comparison of five maintenance therapies for reflux esophagitis. , 1995, The New England journal of medicine.
[19] Y. K. Chen,et al. Gastroesophageal reflux disease in the elderly: more severe disease that requires aggressive therapy. , 1995, The American journal of gastroenterology.
[20] O. James,et al. Comparison of omeprazole and histamine H2-receptor antagonists in the treatment of elderly and young patients with reflux oesophagitis. , 1994, Age and ageing.
[21] P GUEDJ,et al. The Esophagus , 2005, The American Journal of Digestive Diseases.
[22] T. Halvorsen,et al. Hiatus hernia in gastroesophageal reflux disease. , 1986, Scandinavian journal of gastroenterology.